UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Blood, 2012-04, Vol.119 (17), p.3940-3950

2012

Volltextzugriff (PDF)

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Blood, 2008-09, Vol.112 (6), p.2261-2271

2008

Volltextzugriff (PDF)

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains

Human gene therapy, 2007-08, Vol.18 (8), p.712-725

2007

Volltextzugriff (PDF)

Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8+ Cytotoxic T Lymphocytes

Molecular therapy, 2004-04, Vol.9 (4), p.577-586

2004

Volltextzugriff (PDF)

53. Preliminary Results of a Pilot Phase I Clinical Trial of Adoptive Immunotherapy for B Cell Lymphoma Using CD8+ T Cells Genetically Modified To Express a Chimeric T Cell Receptor Recognizing CD20

Molecular therapy, 2006-05, Vol.13 (S1), p.S22-S23

2006

Volltextzugriff (PDF)

T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse

Blood, 2014-12, Vol.124 (21), p.3711-3711

2014

Volltextzugriff (PDF)

Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells

Cancer research (Chicago, Ill.), 1989, Vol.49 (1), p.235-240

1989

Volltextzugriff (PDF)

Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies

Cancer research (Chicago, Ill.), 1989-10, Vol.49 (20), p.5509-5513

1989

Volltextzugriff (PDF)

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

Cancer research (Chicago, Ill.), 1987-08, Vol.47 (15), p.4202-4207

1987

Volltextzugriff (PDF)

Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma

Blood, 2010-11, Vol.116 (21), p.561-561

2010

Volltextzugriff (PDF)

Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro

Cancer research (Chicago, Ill.), 1989-12, Vol.49 (23), p.6487-6492

1989

Volltextzugriff (PDF)

Adoptive Cellular Therapy for Follicular Lymphoma Using Genetically-Modified Autologous CD20-Specific T Cells

Blood, 2007-11, Vol.110 (11), p.499-499

2007

Volltextzugriff (PDF)

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients

Cancer research (Chicago, Ill.), 1990-02, Vol.50 (4), p.1160-1164

1990

Volltextzugriff (PDF)

Pentoxifylline Inhibits Integrin-Mediated Adherence of Interleukin-2–Activated Human Peripheral Blood Lymphocytes to Human Umbilical Vein Endothelial Cells, Matrix Components, and Cultured Tumor Cells

Blood, 1994-10, Vol.84 (7), p.2234-2242

1994

Volltextzugriff (PDF)

Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects

Cancer Immunology Immunotherapy, 1987-07, Vol.25 (1), p.47-53

1987

Volltextzugriff (PDF)

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma

The cancer journal from Scientific American, 1997-12, Vol.3 Suppl 1, p.S29

1997

Volltextzugriff (PDF)

The genetic origin and history of speed in the Thoroughbred racehorse

Nature communications, 2012-01, Vol.3 (1), p.643-643, Article 643

2012

Volltextzugriff (PDF)

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance

Nature genetics, 2012-06, Vol.44 (6), p.659-669

2012

Volltextzugriff (PDF)

Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function

Nature genetics, 2022-01, Vol.54 (1), p.18-29

2022

Volltextzugriff (PDF)

Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes

Scientific reports, 2017-11, Vol.7 (1), p.15351-15, Article 15351

2017

Volltextzugriff (PDF)

E-Government Challenges: Methods Supporting Qualitative and Quantitative Analysis

Electronic Government, p.176-187

Volltextzugriff (PDF)

Meta-analysis fine-mapping is often miscalibrated at single-variant resolution

Cell genomics, 2022-12, Vol.2 (12), p.100210, Article 100210

2022

Volltextzugriff (PDF)

Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function

Nature genetics, 2022-01, Vol.54 (1), p.18-4

2022

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)
Tagungsberichte
(2)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(15)
Life Sciences & Biomedicine
(15)
Adult
(6)
Aged
(6)
Biological And Medical Sciences
(6)
Female
(6)
Genetics & Heredity
(6)
Male
(6)
Middle Aged
(6)
Oncology
(6)
Interleukin-2 - Pharmacology
(5)
Medical Sciences
(5)
Gene Therapy
(4)
Humanities And Social Sciences
(4)
Immunotherapy
(4)
Lymphocyte Activation - Drug Effects
(4)
Body Mass Index
(3)
Cancer Research
(3)
Cell Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(7)
Cancer Research
(5)
Nature Genetics
(3)
Cell Genomics
(2)
Molecular Therapy
(2)
Bmj Open
(1)
Cancer Immunology Immunotherapy
(1)
Cancer Immunology, Immunotherapy : Cii
(1)
Human Gene Therapy
(1)
Nature Communications
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains

Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8+ Cytotoxic T Lymphocytes

53. Preliminary Results of a Pilot Phase I Clinical Trial of Adoptive Immunotherapy for B Cell Lymphoma Using CD8+ T Cells Genetically Modified To Express a Chimeric T Cell Receptor Recognizing CD20

T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse

Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells

Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

Phase I Trial Results Testing Adoptively Transferred T Cells Expressing CD20-Specific Chimeric Antigen Receptors Containing CD28 and CD137 Costimulatory Domains In Patients with Mantle Cell Lymphoma and Indolent Lymphoma

Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro

Adoptive Cellular Therapy for Follicular Lymphoma Using Genetically-Modified Autologous CD20-Specific T Cells

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Commentary

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients

Pentoxifylline Inhibits Integrin-Mediated Adherence of Interleukin-2–Activated Human Peripheral Blood Lymphocytes to Human Umbilical Vein Endothelial Cells, Matrix Components, and Cultured Tumor Cells

Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma

The genetic origin and history of speed in the Thoroughbred racehorse

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance

An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol

Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function

Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes

E-Government Challenges: Methods Supporting Qualitative and Quantitative Analysis

Meta-analysis fine-mapping is often miscalibrated at single-variant resolution

Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function

Aktive Filter

Suchergebnisse filtern